Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gülay Hergenç
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Geographic Areas
Disorders
Concepts & Ideas
Chemicals & Drugs
Activities & Behaviors
Anatomy
Sign-in to see full Profile
Network (preview)
41
Onat, Altan
35
can, günay
10
Yazici, Mehmet
10
Karabulut, Ahmet
9
Sansoy, Vedat
8
Sari, Ibrahim
8
Uyarel, Huseyin
8
Albayrak, Sinan
6
Ozhan, Hakan
5
Türkmen, Serdar
5
Keles, Ibrahim
4
Dogan, Yüksel
2
Ceyhan, Köksal
2
DURSUNOGLU, DURSUN
2
Uysal, Omer
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gülay Hergenç (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Onat A; Hergenç G; Ayhan E; Ugur M; Kaya H; Tuncer M; Can G
Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(10):981-8.
-
2009: Onat Altan; Can Günay; Ayhan Erkan; Kaya Zekeriya; Hergenç Gülay
Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
Metabolism: clinical and experimental 2009;58(10):1393-9.
-
2009: Onat Altan; Ayhan Erkan; Hergenç Gülay; Can Günay; Barlan M Metin
Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure.
Metabolism: clinical and experimental 2009;58(7):963-70.
-
2009: Onat Altan; Ozhan Hakan; Erbilen Enver; Albayrak Sinan; Küçükdurmaz Zekeriya; Can Günay; Keles Ibrahim; Hergenç Gülay
Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
International journal of cardiology 2009;135(2):211-7.
-
2009: Onat Altan; Hergenç Gülay; Can Günay
Abdominal obesity criteria for Turkish men and women, and relevance of smoking for obesity/obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2009;9(2):147; author reply 147.
-
2009: Onat Altan; Hergenç Gülay; Küçükdurmaz Zekeriya; Ugur Murat; Kaya Zekeriya; Can Günay; Yüksel Hüsniye
Moderate and heavy alcohol consumption among Turks: long-term impact on mortality and cardiometabolic risk.
Türk Kardiyoloji Dernegi arsivi : Türk Kardiyoloji Derneginin yayin organidir 2009;37(2):83-90.
-
2009: Onat Altan; Hergenç Gülay; Can Günay; Küçükdurmaz Zekeriya
Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Obesity (Silver Spring, Md.) 2009;17(3):564-70.
-
2009: Onat Altan; Ugur Murat; Hergenç Gülay; Can Günay; Ordu Serkan; Dursunoglu Dursun
Lifestyle and metabolic determinants of incident hypertension, with special reference to cigarette smoking: a longitudinal population-based study.
American journal of hypertension 2009;22(2):156-62.
-
2009: Onat Altan; Hergenç Gülay; Yüksel Hüsniye; Can Günay; Ayhan Erkan; Kaya Zekeriya; Dursunoglu Dursun
Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference.
Clinical nutrition (Edinburgh, Scotland) 2009;28(1):46-51.
-
2009: Onat Altan; Hergenç Gülay; Ayhan Erkan; Ugur Murat; Can Günay
Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(11):1389-94.
-
2009: Onat Altan; Hergenç Gülay; Agirbasli Mehmet; Kaya Zekeriya; Can Günay; Unaltuna Nihan E
Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(2):208-15.
-
2008: Ozsait Bilge; Kömürcü Bayrak Evrim; Poda Mehves; Can Günay; Hergenç Gülay; Onat Altan; Humphries Steve E; Erginel Unaltuna Nihan
CETP TaqIB polymorphism in Turkish adults: association with dyslipidemia and metabolic syndrome.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2008;8(5):324-30.
-
2008: Onat Altan; Hergenç Gülay; Küçükdurmaz Zekeriya; Can Günay; Ayhan Erkan; Bulur Serkan
Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
Clinical nutrition (Edinburgh, Scotland) 2008;27(5):732-9.
-
2008: Onat Altan; Yazici Mehmet; Can Günay; Kaya Zekeriya; Bulur Serkan; Hergenç Gülay
Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
American journal of hypertension 2008;21(8):890-5.
-
2008: Onat Altan; Hergenç Gülay; Ozhan Hakan; Kaya Zekeriya; Bulur Serkan; Ayhan Erkan; Can Günay
Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome.
Coronary artery disease 2008;19(3):125-31.
-
2008: Hergenç Gülay; Onat Altan; Sari Ibrahim; Yazici Mehmet; Eryonucu Beyhan; Can Günay
Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Angiology 2008;59(1):26-35.
-
2008: Onat Altan; Can Günay; Hergenç Gülay
Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Metabolism: clinical and experimental 2008;57(2):207-14.
-
2008: Onat Altan; Hergenç Gülay; Can Günay; Karabulut Ahmet
Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers.
Türk Kardiyoloji Dernegi arsivi : Türk Kardiyoloji Derneginin yayin organidir 2008;36(1):7-13.
-
2008: Onat Altan; Hergenç Gülay
Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking.
Atherosclerosis 2008;196(1):479-80.
-
2008: Onat Altan; Hergenç Gülay; Dursunoglu Dursun; Küçükdurmaz Zekeriya; Bulur Serkan; Can Günay
Relatively high levels of serum adiponectin in obese women, a potential indicator of anti-inflammatory dysfunction: relation to sex hormone-binding globulin.
International journal of biological sciences 2008;4(4):208-14.
-
2007: Onat Altan; Hergenç Gülay; Karabulut Ahmet; Albayrak Sinan; Can Günay; Kaya Zekeriya
Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Metabolism: clinical and experimental 2007;56(10):1356-62.
-
2007: Onat Altan; Ozhan Hakan; Esen A Metin; Albayrak Sinan; Karabulut Ahmet; Can Günay; Hergenç Gülay
Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit.
Atherosclerosis 2007;193(2):380-8.
-
2007: Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
International journal of obesity (2005) 2007;31(7):1119-25.
-
2007: Onat Altan; Hergenç Gülay
[On the criteria of metabolic syndrome in predicting incident coronary disease and diabetes in Turkish adults/abdominal obesity and cardiometabolic risk]
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2007;7(2):212-3.
-
2007: Onat Altan; Ozhan Hakan; Can Günay; Hergenç Gülay; Karabulut Ahmet; Albayrak Sinan
[Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2007;7(2):128-33.
-
2007: Onat Altan; Hergenç Gülay; Can Günay
[Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition]
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2007;7(1):29-34.
-
2007: Onat Altan; Sari Ibrahim; Hergenç Gülay; Yazici Mehmet; Uyarel Hüseyin; Can Günay; Sansoy Vedat
Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
Metabolism: clinical and experimental 2007;56(3):348-56.
-
2007: Onat Altan; Hergenç Gülay; Uyarel Hüseyin; Yazici Mehmet; Tuncer Mustafa; Dogan Yüksel; Can Günay; Rasche Kurt
Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance.
Sleep & breathing = Schlaf & Atmung 2007;11(1):23-30.
-
2007: Onat Altan; Uyarel Hüseyin; Hergenç Gülay; Karabulut Ahmet; Albayrak Sinan; Can Günay
Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
Atherosclerosis 2007;191(1):182-90.
-
2007: Onat Altan; Hergenç Gulay; Uyarel Huseyin; Ozhan Hakan; Esen A Metin; Karabulut Ahmet; Albayrak Sinan; Can Gunay; Keles Ibrahim
Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random nondiabetic population sample.
Kidney & blood pressure research 2007;30(2):88-96.
-
2006: Onat Altan; Hergenç Gülay; Uyarel Hüseyin; Can Günay; Ozhan Hakan
Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2006;6(4):314-21.
-
2006: Onat Altan; Uyarel Hüseyin; Hergenç Gülay; Karabulut Ahmet; Albayrak Sinan; Sari Ibrahim; Yazici Mehmet; Keles Ibrahim
Serum uric acid is a determinant of metabolic syndrome in a population-based study.
American journal of hypertension 2006;19(10):1055-62.
-
2006: Onat Altan; Hergenç Gülay; Karabulut Ahmet; Türkmen Serdar; Dogan Yüksel; Uyarel Hüseyin; Can Günay; Sansoy Vedat
Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults.
Preventive medicine 2006;43(2):136-9.
-
2006: Onat Altan; Hergenç Gülay; Türkmen Serdar; Yazici Mehmet; Sari Ibrahim; Can Günay
Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Metabolism: clinical and experimental 2006;55(4):445-52.
-
2006: Onat Altan; Sari Ibrahim; Yazici Mehmet; Can Günay; Hergenç Gülay; Avci Günsel S
Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
International journal of cardiology 2006;108(1):89-95.
-
2005: Onat Altan; Yazici Mehmet; Hergenç Gülay; Dogan Yüksel; Karabulut Ahmet; Sari Ibrahim; Türkmen Serdar; Can Günay; Sansoy Vedat
[Lipoprotein (a) in a population-based study: more significant in Turkish women than men?]
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2005;5(4):271-7.
-
2005: Onat Altan; Hergenç Gülay; Keles Ibrahim; Dogan Yüksel; Türkmen Serdar; Sansoy Vedat
Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
Metabolism: clinical and experimental 2005;54(6):800-8.
-
2005: Onat Altan; Hergenç Gülay; Sari Ibrahim; Türkmen Serdar; Can Günay; Sansoy Vedat
Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
American journal of hypertension 2005;18(3):409-16.
-
2005: Onat Altan; Uzunlar Bülent; Hergenç Gülay; Yazici Mehmet; Sari Ibrahim; Uyarel Hüseyin; Can Günay; Sansoy Vedat
Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Clinical science (London, England : 1979) 2005;108(2):129-35.
-
2003: Onat Altan; Hergenç Gülay; Sansoy Vedat; Fobker Manfred; Ceyhan Köksal; Toprak Sadik; Assmann Gerd
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Atherosclerosis 2003;168(1):81-9.
-
2002: Onat Altan; Ceyhan Köksal; Sansoy Vedat; Basar Omer; Erer Burak; Uysal Omer; Hergenç Gülay
Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women.
International journal of cardiology 2002;86(1):61-9.
-
2001: Onat A; Sansoy V; Yildirim B; Keles I; Uysal O; Hergenç G
C-reactive protein and coronary heart disease in western Turkey.
The American journal of cardiology 2001;88(6):601-7.
Sign-in to see more